SEC Form 4Coverage since Jul 28, 2026
$ATRC insider trading
Over the last 12 months, AtriCure insiders reported no purchases and 5 sales totaling $1.7M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.7M 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ATRC · 12Mvia TradingView
Top insiders · 12m
Yuen Maggie—1× · $134K
Prange Karen—1× · $138K
Doraiswamy VinayakChief Scientific Officer1× · $233K
Noznesky Justin JChief Mktg & Strategy Officer1× · $240K
WEHRWEIN SVEN—1× · $946K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Prange KarenD | ▼ Sale | 3,564 | $38.8 | $138K | -13.5% | — |
| Aug 5, 2026 | Yuen MaggieD | ▼ Sale | 3,500 | $38.42 | $134K | -20% | — |
| Jul 29, 2026 | Noznesky Justin JChief Mktg & Strategy Officer · O | ▼ Sale | 6,182 | $38.8 | $240K | -5.8% | — |
| Jul 28, 2026 | Doraiswamy VinayakChief Scientific Officer · O | ▼ Sale | 6,000 | $38.88 | $233K | -6.5% | — |
| Jul 28, 2026 | WEHRWEIN SVEND | ▼ Sale | 25,000 | $37.84 | $946K | -38.2% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ATRC feed.